What amount sold does Roq.ad Inc. report in Form D filings?

The latest linked filings report $10.9M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Roq.ad Inc.'s most recent SEC filing?

Roq.ad Inc.'s most recent Form D filing was on 2026-11-04.

How many investors does Roq.ad Inc. have?

The most recent Form D filing lists 19 investor(s).

What type of securities does Roq.ad Inc. offer?

Roq.ad Inc.'s SEC Form D filings indicate equity offerings.

Roq.ad Inc.

CIK: 0002142562·Other·PALO ALTO, CA·Corporation

Reported Sold

$10,917,190

Total Filings

Identified Offerings

Last Filed

Nov 4, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other industry

SEC EDGAR

Offering filing timeline

Nov 4, 2026Form D/A — Amendment

Reported sold: $10,917,190 · Target: $14,804,790

Rule 506(b)·19 investors

Changed: Reported amount sold, Offering target, Reported investors

Jun 26, 2026Form D — New notice

Reported sold: $10,304,791 · Target: $13,304,791

Rule 506(b)·17 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

50%

Latest reported sold across 1 identified offering

$10,917,190

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Carsten Frien

Related Person

Appears on 1 filing

Carl Johan Grandinson

Related Person

Appears on 1 filing

Scott Moen

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Nov 4, 2026	Amendment	$14,804,790	$10,917,190	19
Jun 26, 2026	New	$13,304,791	$10,304,791	17

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Agilis Medical, Inc.

Other

Offering target: $10,000,000

Filed Oct 28, 2026